Clinical Trial Update: VolulyteTM in Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Volulyte in patients undergoing cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Postoperative Cardiac Dysfunction

Drugs mentioned

• Volulyte (Hydroxyethyl starch solution)

Snippet

Sponsor: Fresenius Kabi | Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery | Phase 4 | Status: COMPLETED